Filing Details

Accession Number:
0001567619-22-021070
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-11-30 20:14:40
Reporting Period:
2022-11-28
Accepted Time:
2022-11-30 20:14:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
946563 Retractable Technologies Inc RVP Surgical & Medical Instruments & Apparatus (3841) 752599762
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373603 Michael Braden Leonard 65 E Cedar - Suite 2
Zionsville IN 46077
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-11-28 2,400 $2.30 3,918,575 No 4 S Indirect Holding of BML Investment Partners, L.P.
Common Stock Disposition 2022-11-29 250,000 $2.00 3,688,575 No 4 S Indirect Holding of BML Investment Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Holding of BML Investment Partners, L.P.
No 4 S Indirect Holding of BML Investment Partners, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 387,500 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Put Option (obligation to buy) $5.00 2023-01-20 0 0 Indirect
Expiration Date Amount Remaning Holdings Nature of Ownership
2023-01-20 0 0 Indirect
Footnotes
  1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.30 to $2.31. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.
  3. The Fund wrote American-Style put option contracts expiring in January 2023 (the "Put Options") which provide that the Fund will be required to purchase shares of Common Stock at the stated strike price if the counterparty exercises such option. The fund was assigned 144,100 shares and covered the remaining Put Options.